Popat S - Search Results

1

Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications.

Juan O, Popat S. Juan O, et al. Among authors: popat s. Ther Adv Med Oncol. 2017 Mar;9(3):201-216. doi: 10.1177/1758834016687262. Epub 2017 Jan 30. Ther Adv Med Oncol. 2017. PMID: 28344665 Free PMC article. Review.

2

Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Myerson JS, Iqbal SA, O'Brien ME, Popat S. Myerson JS, et al. Among authors: popat s. Clin Lung Cancer. 2010 Sep 1;11(5):E5-8. doi: 10.3816/CLC.2010.n.047. Clin Lung Cancer. 2010. PMID: 20837451

3

Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: the United Kingdom Named Patient Programme.

Khan F, Ottensmeier C, Popat S, Dua D, Dorey N, Ellis S, Szabo M, Upadhyay S, Califano R, Chan S, Lee L, Ali CW, Nicolson M, Bates AT, Button M, Chaudhuri A, Mulvenna P, Shaw HM, Danson SJ. Khan F, et al. Among authors: popat s. Eur J Cancer. 2014 Jul;50(10):1717-1721. doi: 10.1016/j.ejca.2014.03.001. Epub 2014 Apr 10. Eur J Cancer. 2014. PMID: 24726055

4

The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer.

Pender A, Popat S. Pender A, et al. Among authors: popat s. Ther Adv Respir Dis. 2015 Jun;9(3):97-104. doi: 10.1177/1753465815577738. Epub 2015 Mar 22. Ther Adv Respir Dis. 2015. PMID: 25801645 Free article. Review.

5

Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural Effusions.

Puglisi M, Stewart A, Thavasu P, Frow M, Carreira S, Minchom A, Punwani R, Bhosle J, Popat S, Ratoff J, de Bono J, Yap TA, O''Brien M, Banerji U. Puglisi M, et al. Among authors: popat s. Oncology. 2016;90(5):280-8. doi: 10.1159/000444928. Epub 2016 Apr 16. Oncology. 2016. PMID: 27082424

6

First-line Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors for EGFR Mutant Non-small Cell Lung Cancer: And the Winner is….

Juan O, Yousaf N, Popat S. Juan O, et al. Among authors: popat s. Clin Oncol (R Coll Radiol). 2017 Jan;29(1):e1-e4. doi: 10.1016/j.clon.2016.09.007. Epub 2016 Sep 27. Clin Oncol (R Coll Radiol). 2017. PMID: 27686969 No abstract available.

7

Crizotinib for ROS1 patients: One small step in biomarker testing, one giant leap for advanced NSCLC patients.

Juan O, Popat S. Juan O, et al. Among authors: popat s. Lung Cancer. 2017 Feb;104:131-133. doi: 10.1016/j.lungcan.2016.11.007. Epub 2016 Nov 11. Lung Cancer. 2017. PMID: 27863911 No abstract available.

8

Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.

Juan O, Popat S. Juan O, et al. Among authors: popat s. Clin Lung Cancer. 2017 Nov;18(6):595-606. doi: 10.1016/j.cllc.2017.03.002. Epub 2017 Mar 14. Clin Lung Cancer. 2017. PMID: 28377206 Free article. Review.

9

Platinum-based chemotherapy in triple-negative breast cancer.

Sirohi B, Arnedos M, Popat S, Ashley S, Nerurkar A, Walsh G, Johnston S, Smith IE. Sirohi B, et al. Among authors: popat s. Ann Oncol. 2008 Nov;19(11):1847-52. doi: 10.1093/annonc/mdn395. Epub 2008 Jun 20. Ann Oncol. 2008. PMID: 18567607 Free article.

10

Treatment options for small cell lung cancer - do we have more choice?

Puglisi M, Dolly S, Faria A, Myerson JS, Popat S, O'Brien ME. Puglisi M, et al. Among authors: popat s. Br J Cancer. 2010 Feb 16;102(4):629-38. doi: 10.1038/sj.bjc.6605527. Epub 2010 Jan 26. Br J Cancer. 2010. PMID: 20104223 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

399 results

Search Page